Skip to main content

01.08.2011 | Commentary | Ausgabe 4/2011

Critical Care 4/2011

In vivo and in vitro evidence for pleiotropic effects of levosimendan in the intensive care setting

Critical Care > Ausgabe 4/2011
Mehmet Birhan Yilmaz, Alexandre Mebazaa
Wichtige Hinweise

Competing interests

AM received honorarium for lectures from Orion Pharma. MBY declares no competing interests.


Levosimendan, in addition to its inotropic properties, could have anti-inflammatory and anti-oxidative properties, and can potentially decrease the deleterious effects of reactive oxygen species on the tissues. In their study, Hasslacher and colleagues provided not only in vitro but also in vivo evidence that levosimendan could preserve organ function in acute heart failure and septic-shock-induced myocardial depression via cooling down the oxidative burst of circulating cells.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Über diesen Artikel

Weitere Artikel der Ausgabe 4/2011

Critical Care 4/2011 Zur Ausgabe

Neu im Fachgebiet AINS

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update AINS und bleiben Sie gut informiert – ganz bequem per eMail.